The article discusses the potential risks associated with glucosamine supplements, particularly in older adults with Alzheimer’s disease and cognitive decline. Glucosamine, commonly taken to relieve joint pain, has been found to be linked with a 25% higher risk of death within five years for Alzheimer’s patients. Research indicates that while glucosamine might help with joint issues, it could worsen cognitive function and increase the likelihood of progressing from mild cognitive impairment to full-blown Alzheimer’s.
Key findings include:
- Cognitive Decline: People with Alzheimer’s who take glucosamine may experience faster cognitive decline.
- Study on Mice: Animal studies showed that glucosamine exacerbated memory problems in mice with symptoms resembling Alzheimer’s.
- Role of Sugars: An excess of sugar coatings on brain cells may impair protein function, leading to cognitive issues.
Despite past studies suggesting glucosamine could lower dementia risk in cognitively healthy adults, recent findings stress the importance of context. Experts, like Dr. Jacob Teitelbaum, argue that the correlation between glucosamine use and cognitive decline doesn’t imply causation, indicating that the effects of chronic pain from arthritis might be the underlying issue.
Current research is exploring the relationship between sugars in the brain and Alzheimer’s progression, and there’s ongoing investigation into dietary impacts on brain health. Overall, while glucosamine is widely used for arthritis relief, its potential implications for brain health warrant caution.
